Tolerance of a High Protein Nutrition Shake in Individuals on GLP-1

NCT07096739 · Completed

Last updated 2026-05-28

This clinical trial tests whether a high-protein nutrition shake is tolerated by people currently taking GLP-1 medications.

Status Completed The study has finished.

Phase Not applicable Not a phased drug trial (e.g. a device or behavioral study).

Type Interventional (clinical trial)

Design open-label (no blinding) supportive care study

Participants 20 people

Who can join Ages 18–75 · all sexes Healthy volunteers accepted.

Timeline Started 2025-08 · est. completion 2025-09

Where 1 site · Canada

What this study is testing ClinicalTrials.gov NCT07096739 ↗

Description as written by the study sponsor.

Determine if consuming a high protein nutrition shake reduces gastrointestinal symptoms associated with semaglutide injections.

High protein shake Dietary supplement

Subjects in this study will consume the study product for 1 week. Participants will record GI symptoms over the past 24h on 3 days during the week prior to the intervention, and on days 3, 5, and 7 during the intervention. On the first day, overnight fasted participants will be given the product and symptoms will be followed for 2h. 24h dietary recalls will be collected at the beginning and end of the 7-day treatment period.

Main thing measured	Composite GI symptoms score (CSS)
Sponsor	Kate Farms Inc
Conditions studied	GLP-1 Concentration
GLP-1 drugs	—

Full protocol, eligibility, and contacts on ClinicalTrials.gov NCT07096739 ↗